Three articles examine the role of T cells in the anticancer immune response and how they are being used in therapy.
This activity is intended for hematologists and oncologists, pulmonologists and dermatologists.The goal of this activity is to explore advances being made in the harnessing of T cells for cancer immunotherapies.
Approximate Time to Complete: 1.25 hours
Credit Available: Sept. 15, 2016- Sept. 15, 2017
Developed through a partnership between SITC and Medscape.
Upon completion of this activity, participants will be able to:
- Determine how T-cell populations function under normal homeostasis
- Identify how T-cell populations can be manipulated to kill cancer cells